Drug details
Jentadueto XR (linagliptin and metformin hydrochloride extended-release tablets)
type of Antidiabetics, Biguanides/Dipeptyl Peptidase-IV Inhibitors
Jentadueto XR (linagliptin and metformin hydrochloride extended-release) is a dipeptidyl peptidase-4 (DPP-4) inhibitor and biguanide combination product indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both linagliptin and metformin is appropriate. Jentadueto XR is not for treatment of type 1 diabetes or diabetic ketoacidosis.
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- nausea,
- loss of appetite,
- itching,
- vomiting,
- fever,
- shortness of breath,
- fast heartbeats,
- tiredness,
- stomach pain,
- dizziness,
- weakness,
- sore throat,
- burning eyes,
- skin pain,
- red or purple skin rash with blistering and peeling,
- feeling cold,
- rapid weight gain
- unusual muscle pain,
- swelling in your legs or feet, and
- breakdown of the outer layer of skin,
- severe or ongoing pain in your joints,
- fast, slow or irregular heartbeats,
- blistering,
The following drugs are related to Jentadueto XR, either as a replacement or used together:
- Avandia (rosiglitazone maleate)
- Invokana (canagliflozin tablets)
- Zegalogue (dasiglucagon injection)
- Glucotrol XL (glipizide extended release)
- Glucovance (glyburide and metformin)
- Lyumjev (insulin lispro-aabc injection)
- Januvia (sitagliptin phosphate)
- Tradjenta (linagliptin)
- Saxenda (liraglutide [rdna origin]) injection)
- Victoza (liraglutide [rdna] injection)
- Starlix Tablet (nateglinide)
- Symlin (pramlintide acetate injection)
- Prandin (repaglinide)
- Tolinase (tolbutamide tablets)